Making a direct appeal to teens, the Consumer Healthcare Products Association has created the website DXMstories.org that directly engages young adults around the dangers of dextromethorphan abuse with provocative video clips featuring peer anecdotes.
A worldwide provider of managed videoconferencing, telepresence and visual collaboration services has partnered with Telemed Ventures to deliver a managed visual collaboration solution to Walmart's retail medical clinics.
The Food and Drug Administration on Thursday warned parents against administering benzocaine to their teething babies and advised that parents not use benzocaine at all in children under the age of 2 years unless under the supervision of a family physician.
The House of Representatives on Wednesday passed legislation that reauthorizes the Food and Drug Administration’s prescription drug user fee programs that are scheduled to expire in September. H.R. 5651 passed the House by a vote of 387 to 5.
Walgreens-owned clinic operator Take Care Clinics now is offering three new diagnostic tests and administrative physicals — a move that also advances the Well at Walgreens strategy to enhance services as a community healthcare provider and transform to a health and daily living destination.
Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser's Delsym, an extended-release oral liquid suspension containing dextromethorphan.
A Walgreens study released Wednesday has found that patients starting high cholesterol medication for the first time who participated in enhanced face-to-face counseling sessions with a community pharmacist demonstrated better medication adherence than those who did not participate in the sessions.
The House of Representatives will vote to repeal limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medications as early as June 4, according to a report published online by The Hill, a Washington, D.C.-based political newspaper.
At the start of the article titled "Retail Clinics and Drug store Medicine" published in the Journal of the American Medical Association, author Christine Cassell, a physician, acknowledges that retail-based clinics have been "criticized in some quarters" but states that, despite this, the clinics have experienced success by patient satisfaction and quality scores. The fact that this message is coming from a physician makes it especially important.
Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.